Skip to main content

Mary Louise Z. Collins, MD

Academic Title:

Clinical Associate Professor

Primary Appointment:

Ophthalmology and Visual Sciences

Location:

Towson MD 21204

Phone (Primary):

443-849-2644

Fax:

443-849-2648

Education and Training

1982                B.S., Biological Sciences, University of Maryland, College Park, Maryland

1984                M.S., Microbiology, University of Maryland,          Baltimore, Maryland                   

1988                M.D., Georgetown University School of Medicine, Washington, DC

1988-1989      Internship in Internal Medicine, Union Memorial Hospital, Baltimore, MD

1989-1992      Resident in Ophthalmology, Wills Eye Hospital, Philadelphia, PA

1992-1993      Fellowship in Pediatric Ophthalmology and Strabismus, Children's National Medical  Center, Washington, DC

 

Highlighted Publications

Lepe-Zuniga, JL, Zigler, JS, Jr., Zimmerman, ML, and Gery, I.  Demonstration and

characterization of human intracellular interleukin-1.  In: Thymic Hormones and Lymphokines. Ed. Goldstein, AL, Plenum Publishing Co., USA, 1984.

Lepe-Zuniga, JL, Zigler, JS, Jr., Zimmerman, ML, and Gery, I.  Differences between

intra and extracellular Interleukin-1.  Molecular Immunology. 1984; 22:1387-94.

Falkler, Jr., WA, Zimmerman, ML, Martin, SA and Hall, ER.  The effect of smokeless

tobacco extracts on the growth of oral bacteria of the Genus Streptococcus.  Archives of Oral Biology. 1987; 32:221-23.

Collins, MLZ, Falkler, Jr., WA, Hall, ER, and Graham, MB.  Serological studies of

Peptostreptococci using an indirect fluorescent antibody test.  Journal of Dental Research. 1989; 68:1508-12.

Collins, MLZ, Traboulsi, EI and Maumenee, IH.  Optic nerve head swelling and optic atrophy in the systemic mucopolysaccharidoses.  Ophthalmology. 1990; 97(11):1445-49.

Collins, MLZ, Nelson LB and Parlato, CJ.  Ophthalmic and systemic manifestations of child abuse in Duane's Foundations of Clinical Ophthalmology. 1994; 5(44): 1-13,  J.B. Lippincott Co., Philadelphia.

Shields, JA, Eagle, RC, Jr., Shields, CL, Collins, MLZ and DePotter, P.  Iris juvenile xanthogranuloma studied by immunohistochemistry and flow cyometry.  Ophthalmic Surgery and Lasers. 1997; 28(2): 140-144.

Steinkuller, PG, Du, L, Gilbert, C, Foster, A, Collins, MLZ.  Childhood blindness.

Journal of the American Association for Pediatric Ophthalmology and Strabismus.1999; 3(1): 26-32. 

Engle EC, McIntosh N, Yamada K, Lee BA, Johnson R, O’Keefe M, Letson R, London A, Ballard E, Ruttum M, Matsumoto N, Saito N, Collins MZ, Morris L, Del Monte MA, Magli A, deBeradinis T.  CFEOM1, the classic familial form of congenital fibrosis of the extraocular muscles, is genetically heterogeneous but does not result from mutation in ARIX.  BMC Genetics. 2002; 3:3.

Pediatric Eye Disease Investigator Group. The clinical profile of moderate amblyopia in children younger than 7 years. Arch Ophthalmol. 2002; 120:281-7.

Pediatric Eye Disease Investigator Group.  A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children.  Archives of Ophthalmology. 2002:120:268-278.

Pediatric Eye Disease Investigator Group.  The course of moderate amblyopia treated with atropine in children: experience of the Amblyopia Treatment Study.  Am J Ophthalmol. 2003; 136:630-639.

Pediatric Eye Disease Investigator Group.  Impact of patching and atropine on the child and family in the amblyopia treatment study.  Arch Ophthalmol. 2003; 121: 1625-1632.

Pediatric Eye Disease Investigator Group.  A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors.  Ophthalmology. 2003; 110:1632-1638.

Parikh, V.,Shugart, Y, Doheny,K, Zhang,J, Lan,Li, Williams,J, Hayden,D, Craig,B. Capo,H, Chamblee,D, Chen,C, Collins,M, Dankner,S, Fiergang,D, Guyton,D, Hunter,D, Hutcheon,M, Keys,M Morrison,N, Munoz,M, Parks,M, Plotsky,D, Protzko,E, Repka,M, Sarubbi,M, Schnall,B, Siatkowski,M, Traboulsi,E, Waeltermann,J, Nathans,J. A strabismus susceptibility locus on chromosome 7p. www.pnas.org/cgi/doi/10.1073/pnas.2035118100

Pediatric Eye Disease Investigator Group.  Two-Year Follow-up of a 6 month randomized trial of atropine vs. patching for treatment of moderate amblyopia in children.  Arch Ophthalmol. 2005; 123: 149-157.

Repka MX, Holmes JM, Melia M, Beck RW, Gearinger MD, Tamkins SM, Wheeler DT, Pediatric Eye Disease Investigator Group. The effect of amblyopia treatment on ocular alignment. J AAPOS. 2005; 9:542-5.

Pediatric Eye Disease Investigator Group. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology 2006; 113:895-903.

Pediatric Eye Disease Investigator Group. A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology 2006; 113:904-12.

Repka MX, Melia M, Eibschitz-Tsimhoni M, London R, Magoon E, Pediatric Eye Disease Investigator Group. The effect on refractive error of unilateral atropine as compared with patching for the treatment of amblyopia. J AAPOS. 2007; 11:300-2.

Pediatric Eye Disease Investigator Group. Treatment of strabismic amblyopia with refractive correction. Am J Ophthalmol 2007; 143(6): 1060-3.

Pediatric Eye Disease Investigator Group. Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology 2008; 115:577-84.

Pediatric Eye Disease Investigator Group. Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children less than four years old. J AAPOS 2008;12:451-5.

Pediatric Eye Disease Investigator Group. Repeat probing for treatment of persistent nasolacrimal duct obstruction. J AAPOS 2009; 13(3):306-7.

McCarus, C and Collins, MLZ. Convergence insufficiency: when and how to treat. American Orthoptic Journal. 2009 59:10-13.

Pediatric Eye Disease Investigator Group. A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children. Ophthalmology 2010; 117(5):998-1004.

Tischfield, M et al.  Human TUBB3 Mutations Perturb Microtubule Dynamics, Kinesin Interactions, and Axon Guidance.  Cell. 2010:140: 74-87.

Rutstein RP, Foster NC, Cotter SA, et al. for the Pediatric Eye Disease Investigator Group. Visual acuity through Bangerter filters in non-amblyopic eyes. J AAPOS 2011; 15(2): 131-4.

Pediatric Eye Disease Investigator Group.  A Randomized Trial of Increasing Patching for Amblyopia. Ophthalmology 2013 Nov; 120(11): 2270-7.

Pediatric Eye Disease Investigator Group.  A Randomized Trial Comparing Part-time Patching with Observation for Children 3 to 10 years of Age with Intermittent Exotropia.  Ophthalmology 2014 Dec; 121(12): 2299-2310.

Collins, MLZ. Strabismus in Cerebral Palsy: When and Why to Operate. Amer Orthoptic Journal. 2014: 64:17-20.

Collins, MLZ.  Retinoblastoma: The Zimmerman Family Story. JAMA Ophthalmology. 2014:132(5): 519-520.

Leske DA, Holmes, JM, Melia, M on behalf of Pediatric Eye Disease Investigator Group. Evaluation of the Intermittent Exotropia Questionnaire using Rasch Analysis. JAMA Ophthalmol. 2015; 133(4): 461-465.

Wallace DK, Lazar EL, Crouch ER III, Hoover DL, Tamkins SM on behalf of Pediatric Eye Disease Investigator Group.  Time course and predictors of amblyopia improvement with 2 hours of daily patching. JAMA Ophthalmol. 2015; 133(5): 606-609

Grants and Contracts

2000 – present         Pediatric Eye Disease Investigator Group

PI for GBMC site in multi-center randomized clinical trials in pediatric ophthalmology and strabismus

Amblyopia Treatment Studies #1,3,5, 7, 10, 15, 18

Congenital Esotropia Observation Study

Nasolacrimal Duct Obstruction Study

Intermittent exotropia studies 2, 3

Hyperopia Treatment Study

Study on Adult Strabismus